After adaptation, it becomes a powerful advantage for weight loss and may actually support higher energy levels than pure GLP-1 agonists achieve
Several drugs are in advanced clinical trials: In Phase III trials: IBI362 (Innovent/Eli Lilly), CagriSema (Novo Nordisk), Retatrutide (Eli Lilly), and Survodutide (Boehringer Ingelheim)
33480193 Kim D, Kim JM, Cho YW, Yang KI, Kim DW, Lee ST, No YJ, Seo JG, Byun JI, Kang KW, Kim KT
We will look at how this master antioxidant functions in the body and whether it prevents or contributes to the greying process
Evaluation of antioxidant properties and determination of phenolic and carotenoid profiles of chestnut bee pollen collected from Turkey